Private Label Arbutin Kojic Acid Eye Cream – Low MOQ

The realistic MOQ for a private label arbutin kojic acid eye cream depends primarily on whether you choose a stock formula or commission a custom one. Stock-formula manufacturers — labs that already have a validated brightening eye cream base they'll fill under your brand — typically accept runs as low as 200 to 500 units. This is the fastest and cheapest route and is ideal for founders testing a new market or launching a hero SKU without committing significant capital upfront. Semi-custom development, where a cosmetic chemist adjusts an existing base to your preferred actives concentration, texture, or fragrance profile, usually requires 500 to 1,000 units per run. The higher minimum reflects the additional R&D and formulation time the lab invests before production can begin. Fully custom formulation — building the arbutin and kojic acid eye cream from scratch to your exact specification — generally starts at 1,000 units and more commonly 2,000 units, because the lab must amortize development costs across the batch. Some specialty manufacturers will go lower, but expect to pay a development retainer of $1,500 to $5,000 that is sometimes credited against your first order. Several factors can move MOQs up or down. Specialty actives sourced in small quantities (high-purity alpha-arbutin, for instance) drive MOQs higher because suppliers sell ingredients in minimum pack sizes. Packaging choice matters enormously: an airless pump with custom tooling carries a higher MOQ than a stock airless pump already held in the lab's inventory. Order frequency also helps — labs are more willing to reduce per-run MOQs for brands that commit to quarterly reorders. Regionally, Asian manufacturers (particularly those based in South Korea and China) often offer lower MOQs — sometimes 100 to 200 units — because their production lines are optimized for smaller batch changeovers. However, lead times for shipping, customs, and quality inspection add 4 to 8 weeks and introduce supply-chain risk that domestic US or EU manufacturers avoid. The most common mistake first-timers make is negotiating aggressively on MOQ without also clarifying what is included at that minimum — sometimes a 200-unit MOQ excludes printed labels, stability testing, or secondary carton insertion, all of which add cost and time separately. AJ Cosmo Labs lets you post a brief that specifies your target MOQ and immediately surfaces manufacturers whose listed minimums match your run size, saving the back-and-forth of qualifying labs one by one.

Per-unit cost for a private label arbutin kojic acid eye cream is driven by four main variables: actives concentration, fill volume, packaging type, and order quantity. Understanding each helps you budget accurately before you approach manufacturers. Actives concentration is the biggest cost lever. Alpha-arbutin is a relatively expensive cosmetic active; at 1–2% inclusion in a 15 mL fill, it can add $0.80 to $2.00 per unit in raw-material cost alone. Kojic acid is cheaper but requires a chelating and antioxidant co-system to stay stable, which adds formulation complexity and cost. If you're targeting clinical-grade concentrations (alpha-arbutin above 2%, kojic acid at the regulatory maximum for your market), budget on the high end of every range. Fill volume matters because eye creams are typically small — 10 mL, 15 mL, or 30 mL — but the per-mL manufacturing cost at these volumes is higher than for a 50 mL face cream because setup and filling time don't scale linearly. A 15 mL airless pump fill at 500 units typically lands between $5 and $9 per unit before labels. Packaging type has an outsized impact at low MOQs. Stock airless pumps or tubes held in the manufacturer's inventory add $0.80 to $2.50 per unit. Custom-molded or custom-decorated packaging at low volumes can add $2 to $6 per unit because tooling and minimum component orders are amortized over a smaller run. Order quantity affects the cost band significantly. At 200 units (stock formula), expect $6 to $10 per finished unit inclusive of filling and stock packaging. At 1,000 units on a semi-custom formula, the same product often lands at $5 to $8 per unit. At 5,000+ units with custom packaging, economies of scale can bring per-unit costs under $4 for a straightforward formula. Items that are commonly excluded from quoted per-unit costs include: third-party stability testing ($800 to $3,000 per formula), regulatory safety assessment (required for EU, typically $500 to $1,500), custom label printing ($0.15 to $0.60 per label depending on material and quantity), secondary carton design and printing, and outbound freight. Development fees are a separate line item. Expect $1,500 to $5,000 for a fully custom formula, sometimes waived or credited on semi-custom work if you meet a production minimum. A good practice before finalizing any quote is to ask manufacturers for an itemized cost breakdown rather than a single per-unit price, so you can compare quotes from different labs on equal footing. The AJ Cosmo Labs iOS app lets you collect and compare multiple manufacturer quotes for the same brief in one place, making apples-to-apples comparison much faster.

Lead time from first conversation to finished goods varies considerably depending on whether you choose a stock formula or custom development, and whether your packaging is off-the-shelf or custom-sourced. For stock-formula private label — where the cosmetic chemist already has a validated arbutin kojic acid base and you're applying your own label — the realistic timeline is 4 to 8 weeks. This window covers label artwork approval, label printing, filling, quality inspection, and outbound shipment preparation. Some labs can compress this to 3 weeks for simple stock fills, but that requires artwork to be approved within the first few days and no revisions. For semi-custom development (modifying a stock base to adjust actives concentration, add a peptide booster, or change the texture profile), add 4 to 6 weeks to accommodate formula adjustment, internal stability screening, and a sample approval round. Total lead time is typically 8 to 12 weeks. Fully custom formulation adds the most time. A cosmetic chemist must develop the formula, prepare initial prototypes, iterate based on your feedback, and run accelerated stability testing before the lab will approve it for production. Accelerated stability at 40 °C / 75% RH for a minimum of 4 weeks is standard practice; many manufacturers also require a compatibility test with your chosen packaging. Add regulatory safety assessment time if you're targeting EU or UK markets. In total, custom development runs 12 to 20 weeks from signed development agreement to finished first production run. Common delays that extend timelines include: slow artwork approval on your end (the single most common cause of delay, often adding 2 to 4 weeks), packaging component backorders (airless pumps were particularly supply-constrained in 2021–2023 and delays can still occur), formula revisions after sample review, and regulatory back-and-forth for export markets. If you have a hard launch date — a trade show, a retail shelf date, or a crowdfunding campaign — work backwards from that date and add a 20% buffer. Share the deadline with manufacturers upfront; labs often prioritize clients with firm, credible timelines. AJ Cosmo Labs allows you to specify your target launch date in your project brief so manufacturers can self-select based on their current production capacity, reducing the risk of partnering with a lab that can't hit your window.

Kojic acid is a melanin-inhibiting active derived from fungal fermentation (most commonly Aspergillus oryzae). Its safety profile for the periorbital area is acceptable at low concentrations when formulated correctly, but it requires careful handling compared to other brightening actives. In terms of skin tolerance, kojic acid can cause contact dermatitis in sensitive individuals, particularly at concentrations above 1%. The eye area has thinner, more permeable skin than the rest of the face, which means actives penetrate more readily and irritation potential is higher. A well-formulated eye cream will buffer kojic acid within a pH range of 4.5 to 5.5 and include a soothing co-system — niacinamide, allantoin, or panthenol are common — to offset potential reactivity. Ophthalmological testing (non-irritating to eyes, tested per ISO 10093 or similar) is worth requesting from manufacturers, especially if you plan retail distribution where returns and complaints matter. On the regulatory side, the picture varies by market. In the United States, kojic acid in a cosmetic product has no specific concentration limit set by the FDA; the manufacturer is responsible for safety substantiation. In the European Union, kojic acid is listed in Annex III of EC Regulation 1223/2009 as a restricted substance, currently permitted at a maximum of 1% in face creams and hand creams — eye creams occupy a gray zone that should be clarified with a regulatory consultant. The UK follows similar restrictions post-Brexit under the UK Cosmetics Regulation. Japan classifies kojic acid as a quasi-drug whitening agent under a separate regulatory pathway; if you plan to sell in Japan, a different registration and labeling structure is required. Canada's Cosmetic Ingredient Hotlist should also be reviewed. Alpha-arbutin is generally better tolerated than kojic acid and faces fewer regulatory restrictions globally, making it the preferred primary brightening active in many eye cream formulas, with kojic acid included as a secondary active at lower concentrations. The most common first-timer mistake is formulating at the maximum permitted kojic acid concentration in a single market without checking whether those levels are also permitted in all target export markets, leading to costly reformulation before expansion. AJ Cosmo Labs connects you with cosmetic chemists and regulatory consultants who specialize in brightening actives across multiple markets, so you can validate your formula's regulatory compliance before committing to a production run.

Finding a reliable private label manufacturer for a specialized formula like an arbutin kojic acid eye cream requires more diligence than a generic moisturizer sourcing project, because fewer labs have experience working with kojic acid's stability challenges and the sensitivities of the periorbital zone. Start with specialization, not size. A large contract manufacturer with 50 filling lines may not be the best partner for a 500-unit run of a pH-sensitive brightening cream. Look for mid-size labs — typically 10 to 50 employees — that list brightening, depigmentation, or active-ingredient formulation as a core competency. Ask specifically whether they have existing stock formulas with kojic acid and alpha-arbutin, and request a sample before engaging further. Vetting criteria to apply to every candidate: confirmed GMP certification (ISO 22716 is the international standard for cosmetic manufacturing; NSF/ANSI 455-2 is the US equivalent); a reference client list with at least one brand you can call; stability testing infrastructure (in-house climate chambers or third-party lab partnerships); and willingness to provide a Certificate of Analysis for each batch. Red flags that indicate an unqualified manufacturer include: inability to provide a Safety Data Sheet or INCI list for any stock formula they offer; resistance to sharing a sample before ordering; no stated GMP certification; requests for full payment upfront with no milestone structure; and vague answers about their preservative system or challenge testing methodology. Geographically, strong clusters of qualified cosmetic contract manufacturers exist in the US (particularly in California, New Jersey, and Texas), South Korea (Seoul and Incheon), Italy (Milan and surrounding regions), and China (Guangdong province). Each geography has tradeoffs in MOQ, cost, lead time, regulatory orientation, and communication ease. Traditional sourcing methods — trade show directories, LinkedIn searches, cold outreach to labs — are time-consuming and often surface unvetted manufacturers. AJ Cosmo Labs streamlines this by maintaining a curated directory of pre-screened cosmetic manufacturers and cosmetic chemists accessible directly from the iOS app. You post a single brief describing your arbutin kojic acid eye cream specification, your MOQ, and your timeline, and qualified manufacturers respond with proposals. This approach typically surfaces three to five relevant quotes within 48 to 72 hours — far faster than individual outreach. Download the AJ Cosmo Labs app from the App Store to get started.

A formulation brief is the single document that allows cosmetic manufacturers and cosmetic chemists to quote accurately, propose relevant stock formulas, or scope custom development. A vague brief produces vague (and often useless) quotes; a detailed brief gets you comparable, actionable proposals. The core elements every brief should include are: target actives and desired concentrations (e.g., alpha-arbutin 2%, kojic acid 0.5%), secondary functional ingredients (peptides, caffeine for de-puffing, hyaluronic acid for hydration), preferred preservative system if you have a position on it (phenoxyethanol-free, paraben-free, etc.), and any ingredient exclusions driven by your brand positioning or target retail channel. Texture and skin-feel preferences are often overlooked but matter enormously for the periorbital zone. Specify whether you want a lightweight serum-cream, a rich eye balm, a gel-cream hybrid, or a traditional emulsion. Describe how the product should feel on application — tacky, silky, fast-absorbing, or occlusive — because cosmetic chemists use these descriptors to select emollients and rheology modifiers. Packaging specification should be included from the start, not treated as an afterthought. State your fill volume, preferred dispensing mechanism (airless pump, squeeze tube, doe-foot applicator, dropper), and any packaging sustainability requirements (recyclable, PCR content). Packaging choice directly affects which manufacturers can serve you — not all labs have filling equipment compatible with all closure types. Target markets and regulatory scope must be stated clearly. If you're selling in the US only, the brief is simpler. If you're targeting the EU, UK, Canada, or Australia, the manufacturer needs to know so they can flag actives restrictions and build the appropriate safety documentation into their quote. Commercial parameters — target MOQ, budget per unit (or total budget for the first run), and desired launch date — should be stated honestly. Manufacturers use these to determine whether the project is commercially viable for their production scale. Being vague about budget wastes both parties' time. Finally, include any existing brand assets: logos, color palette, packaging mockups if available, and positioning language. Some labs have in-house design support for label layout. When you post a brief on AJ Cosmo Labs, the app's structured template prompts you through each of these categories so nothing gets missed, and the brief is delivered simultaneously to multiple relevant manufacturers — saving days of individual outreach.

Yes, private label brightening eye creams with arbutin and kojic acid can be sold on Amazon and in retail stores, but each channel has specific requirements that affect how your product must be manufactured, tested, and labeled. For Amazon in the United States, all cosmetic products must comply with FDA cosmetic regulations under the Modernization of Cosmetics Regulation Act (MoCRA), which came into full effect in 2024. This includes facility registration for your manufacturer, cosmetic product listing, and safety substantiation on file. Amazon itself has a cosmetics compliance policy that requires your INCI list to match your label, prohibits certain drug claims (anything that implies the product changes skin structure, like 'permanently reduces melanin production,' crosses into drug-claim territory), and may require third-party lab testing for certain categories. Ensure your product claims stay within cosmetic territory — 'visibly brightens the appearance of dark circles' is safer than 'inhibits melanin synthesis.' For retail stores — independent beauty boutiques, regional chains, or national retailers — the requirements escalate. Most buyers at regional and national chains will ask for proof of liability insurance (typically $1–2 million per occurrence), a Safety Data Sheet, stability data, and often a Consumer Use Test or RIPT (Repeat Insult Patch Test). Some natural or clean beauty retailers maintain ingredient blacklists that may flag kojic acid; confirm the retailer's accepted-ingredients policy before approaching their buying team. For EU retail or EU Amazon, you must comply with EC Regulation 1223/2009, which requires a Cosmetic Product Safety Report signed by a qualified safety assessor, a Product Information File, EU facility notification through the CPNP portal, and a designated Responsible Person within the EU. This adds $500 to $2,000 in regulatory cost before your first EU sale. The most common mistake indie founders make when entering retail is underestimating the compliance documentation burden and discovering the gap only after a buyer requests it — at which point production may already be complete. Build regulatory compliance into your pre-production checklist, not as a post-launch fix. AJ Cosmo Labs connects you not only with cosmetic manufacturers but also with regulatory consultants who can review your product dossier for your target retail channel before you commit to a production run.